Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000233568 | SCV000289821 | uncertain significance | Hereditary breast ovarian cancer syndrome | 2015-11-25 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature. In summary, this is a novel missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. This sequence change replaces leucine with arginine at codon 1705 of the BRCA1 protein (p.Leu1705Arg). The leucine residue is highly conserved and there is a moderate physicochemical difference between leucine and arginine. |
Brotman Baty Institute, |
RCV001076407 | SCV001242150 | not provided | Breast-ovarian cancer, familial, susceptibility to, 1 | no assertion provided | in vitro |